SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004101
Filing Date
2021-11-10
Accepted
2021-11-10 16:21:41
Documents
88
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q me-20210930.htm   iXBRL 10-Q 4332416
2 EX-10.1 me-ex10_1.htm EX-10.1 46633
3 EX-10.2 me-ex10_2.htm EX-10.2 38300
4 EX-31.1 me-ex31_1.htm EX-31.1 29470
5 EX-31.2 me-ex31_2.htm EX-31.2 27315
6 EX-32.1 me-ex32_1.htm EX-32.1 19074
7 EX-32.2 me-ex32_2.htm EX-32.2 19083
  Complete submission text file 0000950170-21-004101.txt   16556486

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20210930_def.xml EX-101.DEF 362451
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20210930_pre.xml EX-101.PRE 524586
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20210930.xsd EX-101.SCH 84451
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20210930_lab.xml EX-101.LAB 634190
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20210930_cal.xml EX-101.CAL 51134
13 EXTRACTED XBRL INSTANCE DOCUMENT me-20210930_htm.xml XML 3965513
Mailing Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086
Business Address 223 NORTH MATHILDA AVENUE SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 211396991
SIC: 2834 Pharmaceutical Preparations